Table of contents

01 Pre-Meeting Briefing prepared by NICE

02 Submission from the technology manufacturer - Novartis

03 NICE request to the manufacturer for clarification on their submission

04 Manufacturer clarification response

05 Consultee submission - British Association of Dermatologists

06 Consultee submission - Psoriasis Association

07 Consultee submission - Psoriasis and Psoriatic Arthritis Alliance

08 Clinical expert personal perspective - CHANDLER

09 Clinical expert personal perspective - MURPHY

10 Clinical expert personal perspective - SMITH

11 Evidence Review Group report prepared by Aberdeen HTA Group

12 Evidence Review Group report erratum

13 Manufacturer factual accuracy check of Evidence Review Group report